[New therapeutic aspects in Kawasaki syndrome and personal experiences].

Kawasaki disease is an inflammatory disease of unknown etiology. The prognosis depends mainly on cardiac, mostly coronary involvement which can be significantly reduced with the use of immunoglobulins. The current recommended therapy consists of a single dose of immunoglobulins (2 g/kg i.v.) combined with acetylsalicylic acid. During 1984-1992 we diagnosed Kawasaki disease in 35 patients. Three of them not treated with immunoglobulins developed coronary aneurysms.
AuthorsU Neudorf
JournalInfusionstherapie und Transfusionsmedizin (Infusionsther Transfusionsmed) Vol. 20 Suppl 1 Pg. 137-9 (Apr 1993) ISSN: 1019-8466 [Print] SWITZERLAND
Vernacular TitleNeue therapeutische Aspekte zum Kawasaki-Syndrom und eigene Erfahrungen.
PMID8499743 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Aspirin
  • Prednisone
  • Aspirin (administration & dosage)
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Immunization, Passive
  • Male
  • Mucocutaneous Lymph Node Syndrome (immunology, therapy)
  • Prednisone (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: